Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 168

    1.

    Prevention of plaque rupture: a new paradigm of therapy.

    Forrester JS.

    Ann Intern Med. 2002 Nov 19;137(10):823-33. Review.PMID: 12435220 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Mechanisms of plaque stabilization]

    Müller-Wieland D, Faust M, Kotzka J, Krone W.

    Herz. 1999 Feb;24(1):26-31. Review. German. PMID: 10093010 [PubMed - indexed for MEDLINE]Related articles

    3.

    Coronary risk factors and plaque morphology in men with coronary disease who died suddenly.

    Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R.

    N Engl J Med. 1997 May 1;336(18):1276-82.PMID: 9113930 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes.

    Monroe VS, Kerensky RA, Rivera E, Smith KM, Pepine CJ.

    J Am Coll Cardiol. 2003 Feb 19;41(4 Suppl S):23S-30S. Review.PMID: 12644337 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pluripotential mechanisms of cardioprotection with HMG-CoA reductase inhibitor therapy.

    Rosenson RS.

    Am J Cardiovasc Drugs. 2001;1(6):411-20. Review.PMID: 14728000 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pathophysiology of coronary thrombosis: role of plaque rupture and plaque erosion.

    Shah PK.

    Prog Cardiovasc Dis. 2002 Mar-Apr;44(5):357-68. Review.PMID: 12024334 [PubMed - indexed for MEDLINE]Related articles

    7.

    Vitamin E in cardiovascular disease: has the die been cast?

    Yusoff K.

    Asia Pac J Clin Nutr. 2002;11 Suppl 7:S443-7. Review.PMID: 12492632 [PubMed - indexed for MEDLINE]Related articles

    8.

    High-density lipoprotein metabolism: potential therapeutic targets.

    Davidson MH, Toth PP.

    Am J Cardiol. 2007 Dec 3;100(11 A):n32-40. Review.PMID: 18047851 [PubMed - indexed for MEDLINE]Related articles

    9.

    Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.

    Nicholls SJ, Tuzcu EM, Sipahi I, Grasso AW, Schoenhagen P, Hu T, Wolski K, Crowe T, Desai MY, Hazen SL, Kapadia SR, Nissen SE.

    JAMA. 2007 Feb 7;297(5):499-508.PMID: 17284700 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.

    Zhou J, Chew M, Ravn HB, Falk E.

    Scand J Clin Lab Invest Suppl. 1999;230:3-11. Review.PMID: 10389196 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Pathogenesis of acute coronary syndromes]

    Hao H, Kanmatsuse K, Yutani C.

    Nippon Rinsho. 1998 Sep;56(9):2434-41. Review. Japanese. PMID: 9780733 [PubMed - indexed for MEDLINE]Related articles

    12.

    Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use of surrogate end-points.

    Kinlay S, Selwyn AP, Delagrange D, Creager MA, Libby P, Ganz P.

    Curr Opin Lipidol. 1996 Dec;7(6):389-97. Review.PMID: 9117144 [PubMed - indexed for MEDLINE]Related articles

    13.

    Vulnerable plaque: pathobiology and clinical implications.

    Kullo IJ, Edwards WD, Schwartz RS.

    Ann Intern Med. 1998 Dec 15;129(12):1050-60. Review.PMID: 9867761 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Role of inflammation and metalloproteinases in plaque disruption and thrombosis.

    Shah PK.

    Vasc Med. 1998;3(3):199-206. Review.PMID: 9892512 [PubMed - indexed for MEDLINE]Related articles

    15.

    The oxidation ratio of LDL: a predictor for coronary artery disease.

    Huang H, Mai W, Liu D, Hao Y, Tao J, Dong Y.

    Dis Markers. 2008;24(6):341-9.PMID: 18688083 [PubMed - indexed for MEDLINE]Related articles

    16.

    Factors determining and prevention of atherosclerotic plaque rupture.

    Boudoulas H.

    Postgrad Med J. 1994;70 Suppl 1:S43-5.PMID: 7971648 [PubMed - indexed for MEDLINE]Related articles

    17.

    Atherothrombosis and plaque heterology: different location or a unique disease?

    Slevin M, Wang Q, Font MA, Luque A, Juan-Babot O, Gaffney J, Kumar P, Kumar S, Badimon L, Krupinski J.

    Pathobiology. 2008;75(4):209-25. Epub 2008 Jun 26. Review.PMID: 18580067 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.

    Colquhoun D, Keech A, Hunt D, Marschner I, Simes J, Glasziou P, White H, Barter P, Tonkin A; LIPID Study Investigators.

    Eur Heart J. 2004 May;25(9):771-7.PMID: 15120888 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Mechanisms of acute coronary syndromes and the potential role of statins.

    Dupuis J.

    Atheroscler Suppl. 2001 Feb;2(1):9-14. Review.PMID: 11286155 [PubMed - indexed for MEDLINE]Related articles

    20.

    Association of cholesterol levels and occurrence of angiographically detectable endothelial disruption during coronary angioplasty.

    Rubboli A, Euler DE, Sangiorgio P, Casella G, La Vechia L, Fontanelli A, Bracchetti D.

    Clin Cardiol. 2003 Jul;26(7):336-40.PMID: 12862300 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data